AI eye doctor: QiLin system aims to sharpen injection decisions
NCT ID NCT07328776
First seen Jan 10, 2026 · Last updated May 24, 2026 · Updated 19 times
Summary
This study tests an artificial intelligence system called QiLin that helps doctors decide when to give anti-VEGF injections for retinal diseases like wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. About 200 patients who have completed initial treatment will be randomly assigned to have their injection decisions made by a doctor alone or by a doctor using QiLin. The goal is to see if AI assistance improves the accuracy of treatment decisions compared to expert review.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai general hospital
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai general hospital, Shanghai Jiao Tong University, Shanghai, 200080
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.